Showing results (281-290 of 323) with videos related to

Sort By:
Pageof 33
RMD Open|June 9, 2021
Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: an overview of systematic reviewsSebastián Cruz Rodriguez-García, Raul Castellanos-Moreira, Jacqueline Uson, et al.
Annals of the Rheumatic Diseases|May 26, 2021
EULAR recommendations for intra-articular therapiesJacqueline Uson, Sebastián Cruz Rodriguez-García, Raul Castellanos-Moreira, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 2017
Family Aggregation and Heritability of ESRD in Taiwan: A Population-Based StudyHsin Hsu Wu, Chang Fu Kuo, I Jung Li, et al.
Annals of the Rheumatic Diseases|August 30, 2018
2018 update of the EULAR recommendations for the management of hand osteoarthritisMargreet Kloppenburg, Féline Pb Kroon, Francisco J Blanco, et al.
Trials|March 5, 2013
Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trialSarah R Kingsbury, Puvan Tharmanathan, Joy Adamson, et al.
European Journal of Human Genetics : EJHG|January 27, 2011
The effect of genome-wide association scan quality control on imputation outcome for common variantsLorraine Southam, Kalliope Panoutsopoulou, N William Rayner, et al.
Trials|April 16, 2015
Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trialSarah R Kingsbury, Puvan Tharmanathan, Nigel K Arden, et al.
Science (New York, N.Y.)|April 3, 2025
Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signalingYuanheng Yang, Cong Hao, Tingying Jiao, et al.
Human Molecular Genetics|February 27, 2008
A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibilityKay Chapman, Atsushi Takahashi, Ingrid Meulenbelt, et al.
Neurobiology of Disease|December 3, 2014
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative diseaseErnest S Smith, Alan Jonason, Christine Reilly, et al.
Pageof 33